These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17080256)

  • 1. Phase II clinical and pharmacologic study of radiation therapy and carboxyamido-triazole (CAI) in adults with newly diagnosed glioblastoma multiforme.
    Mikkelsen T; Lush R; Grossman SA; Carson KA; Fisher JD; Alavi JB; Rosenfeld S
    Invest New Drugs; 2007 Jun; 25(3):259-63. PubMed ID: 17080256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers.
    Kohn EC; Reed E; Sarosy G; Christian M; Link CJ; Cole K; Figg WD; Davis PA; Jacob J; Goldspiel B; Liotta LA
    Cancer Res; 1996 Feb; 56(3):569-73. PubMed ID: 8564973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer.
    Hussain MM; Kotz H; Minasian L; Premkumar A; Sarosy G; Reed E; Zhai S; Steinberg SM; Raggio M; Oliver VK; Figg WD; Kohn EC
    J Clin Oncol; 2003 Dec; 21(23):4356-63. PubMed ID: 14645425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New Approaches to Brain Tumor Therapy Central Nervous System Consortium.
    Fetell MR; Grossman SA; Fisher JD; Erlanger B; Rowinsky E; Stockel J; Piantadosi S
    J Clin Oncol; 1997 Sep; 15(9):3121-8. PubMed ID: 9294475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas.
    Omuro A; Beal K; McNeill K; Young RJ; Thomas A; Lin X; Terziev R; Kaley TJ; DeAngelis LM; Daras M; Gavrilovic IT; Mellinghoff I; Diamond EL; McKeown A; Manne M; Caterfino A; Patel K; Bavisotto L; Gorman G; Lamson M; Gutin P; Tabar V; Chakravarty D; Chan TA; Brennan CW; Garrett-Mayer E; Karmali RA; Pentsova E
    J Clin Oncol; 2018 Jun; 36(17):1702-1709. PubMed ID: 29683790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of patients with newly diagnosed glioblastoma multiforme treated with RSR13 and radiotherapy: results of a phase II new approaches to brain tumor therapy CNS consortium safety and efficacy study.
    Kleinberg L; Grossman SA; Carson K; Lesser G; O'Neill A; Pearlman J; Phillips P; Herman T; Gerber M
    J Clin Oncol; 2002 Jul; 20(14):3149-55. PubMed ID: 12118029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
    Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suramin and radiotherapy in newly diagnosed glioblastoma: phase 2 NABTT CNS Consortium study.
    Laterra JJ; Grossman SA; Carson KA; Lesser GJ; Hochberg FH; Gilbert MR;
    Neuro Oncol; 2004 Jan; 6(1):15-20. PubMed ID: 14769135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults.
    Gross MW; Altscher R; Brandtner M; Haeusser-Mischlich H; Chiricuta IC; Siegmann AD; Engenhart-Cabillic R
    Clin Neurol Neurosurg; 2005 Apr; 107(3):207-13. PubMed ID: 15823676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.
    Wen PY; Yung WK; Lamborn KR; Dahia PL; Wang Y; Peng B; Abrey LE; Raizer J; Cloughesy TF; Fink K; Gilbert M; Chang S; Junck L; Schiff D; Lieberman F; Fine HA; Mehta M; Robins HI; DeAngelis LM; Groves MD; Puduvalli VK; Levin V; Conrad C; Maher EA; Aldape K; Hayes M; Letvak L; Egorin MJ; Capdeville R; Kaplan R; Murgo AJ; Stiles C; Prados MD
    Clin Cancer Res; 2006 Aug; 12(16):4899-907. PubMed ID: 16914578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of orally administered carboxyamido-triazole, an inhibitor of calcium-mediated signal transduction.
    Figg WD; Cole KA; Reed E; Steinberg SM; Piscitelli SC; Davis PA; Soltis MJ; Jacob J; Boudoulas S; Goldspiel B
    Clin Cancer Res; 1995 Aug; 1(8):797-803. PubMed ID: 9816048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
    Cloughesy TF; Wen PY; Robins HI; Chang SM; Groves MD; Fink KL; Junck L; Schiff D; Abrey L; Gilbert MR; Lieberman F; Kuhn J; DeAngelis LM; Mehta M; Raizer JJ; Yung WK; Aldape K; Wright J; Lamborn KR; Prados MD
    J Clin Oncol; 2006 Aug; 24(22):3651-6. PubMed ID: 16877733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants. NABTT CNS Consortium. The New Approaches to Brain Tumor Therapy.
    Grossman SA; Hochberg F; Fisher J; Chen TL; Kim L; Gregory R; Grochow LB; Piantadosi S
    Cancer Chemother Pharmacol; 1998; 42(2):118-26. PubMed ID: 9654111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction.
    Kohn EC; Reed E; Sarosy GA; Minasian L; Bauer KS; Bostick-Bruton F; Kulpa V; Fuse E; Tompkins A; Noone M; Goldspiel B; Pluda J; Figg WD; Liotta LA
    Clin Cancer Res; 2001 Jun; 7(6):1600-9. PubMed ID: 11410496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II preradiation R115777 (tipifarnib) in newly diagnosed GBM with residual enhancing disease.
    Lustig R; Mikkelsen T; Lesser G; Grossman S; Ye X; Desideri S; Fisher J; Wright J;
    Neuro Oncol; 2008 Dec; 10(6):1004-9. PubMed ID: 18725460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I and pharmacokinetic study of a micronized formulation of carboxyamidotriazole, a calcium signal transduction inhibitor: toxicity, bioavailability and the effect of food.
    Berlin J; Tutsch KD; Arzoomanian RZ; Alberti D; Binger K; Feierabend C; Dresen A; Marnocha R; Pluda J; Wilding G
    Clin Cancer Res; 2002 Jan; 8(1):86-94. PubMed ID: 11801543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma.
    Dillman RO; Shea WM; Tai DF; Mahdavi K; Barth NM; Kharkar BR; Poor MM; Church CK; DePriest C
    Neuro Oncol; 2001 Jan; 3(1):35-41. PubMed ID: 11305415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patupilone (epothilone B) for recurrent glioblastoma: clinical outcome and translational analysis of a single-institution phase I/II trial.
    Oehler C; Frei K; Rushing EJ; McSheehy PM; Weber D; Allegrini PR; Weniger D; Lütolf UM; Knuth A; Yonekawa Y; Barath K; Broggini-Tenzer A; Pruschy M; Hofer S
    Oncology; 2012; 83(1):1-9. PubMed ID: 22688083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
    BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.